Fig. 3From: Dopamine and dopamine receptor D1 as a novel favourable biomarker for hepatocellular carcinomaDRD1-associated genomic mutations in HCC. a DRD1-associated somatic mutations. b–e The differences in clinical prognosis between the mutation group and the wild-type in terms of OS, DFS, PFS, and DSS. f DRD1 mRNA expression between groups with different mutation types. g DRD1-associated mutation types in HCCBack to article page